Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
1Department of Hematology,University Hospital of Saint-Etienne, 2Department of Immunology,University Hospital of Grenoble-Alpes, 3Department Hematology,University Hospital of Clermont-Ferrand, 4Department of Immunology,University Hospital of Nice, 5Department of Biopathology,Institute Paoli-Calmettes, 6Department of Hematology,University Hospital of Lille
Chapitres
- 00:04Titre
- 01:07Bone Marrow (BM) Sample Preparation
- 02:50Data Acquisition
- 03:53Data Analysis
- 07:48BM Myeloid Compartment Maturation Evaluation
- 10:03Results: Representative Flow Cytometry Analysis of BM Cell Populations in a del(7) MDS Case
- 10:33Conclusion
La diagnosi MDS è difficile in assenza di criteri morfologici o citogenetica non informativo. MFC potrebbe contribuire ad affinare il processo diagnostico MDS. Per diventare utile per la pratica clinica, l'analisi MFC deve basarsi su parametri con sufficiente sensibilità e specificità, e i dati devono essere riproducibili tra operatori diversi.
